- Global network
- About us
-
Knowledge hub
- Clinical Trial Logistics
- Clinical Trial Supply
- Courier Services & Preconditioned Temperature Controlled Packaging
- GxP-Compliant Cold Chain Transport & Storage
- Decentralised Clinical Trials & Direct-to-Patient Logistics
- Labelling of Medicinal Products
- Laboratory Kits Preparation
- Protocol Review & Project Management
Pre-diabetes concerns
Every fourth or fifth person in Kazakhstan is in a state of pre-diabetes, according to a recent study.
The results of the NOMAD study on the prevalence of prediabetes among the population were published November 2022 and the results provide a wake-up call for the country’s inhabitants.
Worryingly symptom-free, pre-diabetes creates an increased risk of developing type 2 diabetes as well as diseases of the circulatory system, cardiovascular diseases and conditions affecting the nervous system.
While genetic predisposition and age can be causes, as a rule, it develops in people who are overweight, with an unhealthy diet and a sedentary lifestyle.
In a screening for prediabetes and type 2 diabetes, the Diabetes Association of the Republic of Kazakhstan examined the risks of more than 5,000 people over six cities. Almost 80% had prediabetes or type 2 diabetes, with an incidence in patients younger than 45 years at 38%.
Patients involved in the study had access to an education and information website - prediabet.kz - which provided detailed information along with tools to determine risk levels and get tested.
It also advised that while prediabetes itself is a serious condition, it doesn’t have to be a life sentence. Early diagnosis, healthy lifestyle changes and fast treatment can achieve extremely positive outcomes.